Impact of radiosurgery on hearing and balance in vestibular schwannoma patients
Official title: Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
Run by University Hospital, Geneva · NCT05641441 · Data updated 2026-11-12
This study is testing how a specific type of radiation treatment affects hearing and balance in people with vestibular schwannoma.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 258 (estimated) |
| Sponsor | University Hospital, Geneva Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Geneva) |
| Status | Recruiting |
| Started | January 24, 2023 |
| Main results expected | November 15, 2030 |
| Study ends | November 15, 2030 |
| Registry record updated | January 13, 2025 |
| Trial ID | NCT05641441 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with unilateral vestibular schwannoma treated with either SRS or MRI-based observation.
✕Probably not a fit
Patients with previous treatments for vestibular schwannoma or those with profound hearing loss may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of stereotactic radiosurgery (SRS) on patients with vestibular schwannoma, focusing on cochlear, vestibular, gustatory, and facial nerve functions. It includes both retrospective analysis of past patients treated between 2014 and 2021 and prospective follow-up of current patients. Data will be collected on demographics, clinical characteristics, and MRI features, alongside quality of life assessments through questionnaires. The aim is to evaluate the predictive value of tumor characteristics on hearing preservation and vestibular function.
Why it matters
Potential benefit: If successful, this study could enhance understanding of how radiosurgery affects hearing and balance, potentially leading to improved treatment strategies for vestibular schwannoma.
How similar studies have gone: While there have been studies on radiosurgery for vestibular schwannoma, this specific focus on ototoxicity and quality of life assessments is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years or above * Patients with unilateral VS treated either with SRS or MRI-based observation strategy, as proposed by the institution's skull base tumor board independently of the study * Patients willing to take part in the study and give their informed consent Exclusion Criteria: * Previous surgical or radiation therapy for VS (including SRS) * Patients diagnosed with neurofibromatosis type II * Preexisting profound hearing loss, with a pure tone average (PTA) \>90 and word recognition score (WRS) \<10%, upon initial assessment * Previous middle ear surgery of the affected ear * Concurrent treatment with other experimental drugs
Where it's running
-
Service d'ORL et Chirurge cervico-faciale, Hopitaux Universitaires de Genève
Geneva, Switzerland Recruiting
Study contacts
- Study coordinator: Pascal Senn
- Email: pascal.senn@hcuge.ch
- Phone: 0223728244
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
3D MRI Elastography to Peek at Vestibular Schwannoma Stiffness and How It Relates to Surgery
This study tests whether 3D MRI elastography can noninvasively measure how stiff vestibular schwannomas are and how firmly they stick to nearby tissues, to help predict surgical difficulty and outcomes.
-
Vestibular rehabilitation for adults having surgery for a unilateral vestibular schwannoma
This trial tests whether home-based vestibular telerehabilitation before and after surgery, and adding preoperative rotatory chair sessions, can help adults recover balance and reduce dizziness after removal of a unilateral vestibular schwannoma.
-
N-acetylcysteine to prevent cisplatin-related hearing loss
This study tests whether N-acetylcysteine (NAC) can prevent hearing loss in adults receiving high-dose cisplatin chemotherapy.
-
Testing brain vestibular centers after vestibular schwannoma surgery with MRI
We’re testing whether brain areas that control balance light up differently in people after vestibular schwannoma surgery compared to healthy individuals using MRI.
-
Steroids to protect facial nerve function after skull-base surgery for vestibular schwannoma
This trial tests whether giving steroids after vestibular schwannoma surgery helps preserve facial nerve function compared with a placebo.
-
Rehabilitation for patients with vestibular deficits using head impulse testing
This study is testing a new rehabilitation method using head movement exercises to help people with balance issues from vestibular problems, like vestibular schwannoma, see if it improves their eye and balance function compared to a simple eye movement treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.